{"id":"https://openalex.org/W4414710210","doi":"https://doi.org/10.1016/j.tranon.2025.102553","title":"USP11 is involved in the sensitivity of liver cancer cells to ferroptosis and taxanes through the regulation of NRF2 ubiquitin-mediated degradation","display_name":"USP11 is involved in the sensitivity of liver cancer cells to ferroptosis and taxanes through the regulation of NRF2 ubiquitin-mediated degradation","publication_year":2025,"publication_date":"2025-10-01","ids":{"openalex":"https://openalex.org/W4414710210","doi":"https://doi.org/10.1016/j.tranon.2025.102553","pmid":"https://pubmed.ncbi.nlm.nih.gov/41033073","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12517085"},"language":"en","primary_location":{"id":"doi:10.1016/j.tranon.2025.102553","doi":"https://doi.org/10.1016/j.tranon.2025.102553","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.tranon.2025.102553","pdf_url":null,"source":{"id":"https://openalex.org/S106638657","display_name":"Translational Oncology","issn_l":"1936-5233","issn":["1936-5233","1944-7124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.tranon.2025.102553","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016969489","display_name":"Shujia Kong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26080491","display_name":"Kunming Medical University","ror":"https://ror.org/038c3w259","country_code":"CN","type":"education","lineage":["https://openalex.org/I26080491"]},{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shujia Kong","raw_affiliation_strings":["Department of Pharmacy, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, Yunnan 650118, China; Faculty of Pharmacy, Kunming Medical University, Yunnan 650500, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, Yunnan 650118, China; Faculty of Pharmacy, Kunming Medical University, Yunnan 650500, China","institution_ids":["https://openalex.org/I26080491","https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049776068","display_name":"Chen Zhao","orcid":"https://orcid.org/0000-0002-3397-4907","observed_orcids":["https://orcid.org/0000-0002-3397-4907"]},"institutions":[{"id":"https://openalex.org/I26080491","display_name":"Kunming Medical University","ror":"https://ror.org/038c3w259","country_code":"CN","type":"education","lineage":["https://openalex.org/I26080491"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chen Zhao","raw_affiliation_strings":["Department of Pharmacy, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, Yunnan 650118, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, Yunnan 650118, China","institution_ids":["https://openalex.org/I26080491"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101609630","display_name":"Jiaxun Li","orcid":"https://orcid.org/0000-0002-3167-4775","observed_orcids":["https://orcid.org/0000-0002-3167-4775"]},"institutions":[{"id":"https://openalex.org/I26080491","display_name":"Kunming Medical University","ror":"https://ror.org/038c3w259","country_code":"CN","type":"education","lineage":["https://openalex.org/I26080491"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jiaxun Li","raw_affiliation_strings":["Department of Pharmacy, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, Yunnan 650118, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, Yunnan 650118, China","institution_ids":["https://openalex.org/I26080491"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xin Pan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26080491","display_name":"Kunming Medical University","ror":"https://ror.org/038c3w259","country_code":"CN","type":"education","lineage":["https://openalex.org/I26080491"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xin Pan","raw_affiliation_strings":["Department of Pharmacy, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, Yunnan 650118, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, Yunnan 650118, China","institution_ids":["https://openalex.org/I26080491"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101524128","display_name":"Yan-Wen Li","orcid":"https://orcid.org/0000-0002-4196-1751","observed_orcids":["https://orcid.org/0000-0002-4196-1751"]},"institutions":[{"id":"https://openalex.org/I26080491","display_name":"Kunming Medical University","ror":"https://ror.org/038c3w259","country_code":"CN","type":"education","lineage":["https://openalex.org/I26080491"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yanwen Li","raw_affiliation_strings":["Intensive Care Unit, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, Yunnan 650118, China. Electronic address: Liyw20008@163.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intensive Care Unit, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, Yunnan 650118, China. Electronic address: Liyw20008@163.com","institution_ids":["https://openalex.org/I26080491"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5101524128"],"corresponding_institution_ids":["https://openalex.org/I26080491"],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":{"value":3390,"currency":"USD","value_usd":3390},"fwci":0.8415,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.66020811,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"62","issue":null,"first_page":"102553","last_page":"102553"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/usp11","display_name":"USP11","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ferroptosis","display_name":"ferroptosis","score":0.9150000214576721},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9769999980926514},{"id":"https://openalex.org/keywords/taxane-sensitivity","display_name":"taxane sensitivity","score":0.796999990940094},{"id":"https://openalex.org/keywords/nrf2","display_name":"Nrf2","score":0.8040000200271606},{"id":"https://openalex.org/keywords/deubiquitination","display_name":"deubiquitination","score":0.9240000247955322},{"id":"https://openalex.org/keywords/ubiquitin-mediated-degradation","display_name":"ubiquitin-mediated proteolysis","score":0.9150000214576721},{"id":"https://openalex.org/keywords/erastin","display_name":"erastin","score":0.8309999704360962},{"id":"https://openalex.org/keywords/slc7a11","display_name":"SLC7A11","score":0.875},{"id":"https://openalex.org/keywords/gpx4","display_name":"GPX4","score":0.9829999804496765},{"id":"https://openalex.org/keywords/glutathione","display_name":"glutathione","score":0.8090000152587891},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.7260000109672546},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.8700000047683716},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9700000286102295},{"id":"https://openalex.org/keywords/cabazitaxel","display_name":"cabazitaxel","score":0.996999979019165},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.5070000290870667},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.7450000047683716}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6262000203132629},{"id":"https://openalex.org/C2776231280","wikidata":"https://www.wikidata.org/wiki/Q623031","display_name":"Liver cancer","level":3,"score":0.6087999939918518},{"id":"https://openalex.org/C2779679103","wikidata":"https://www.wikidata.org/wiki/Q5251805","display_name":"Degradation (telecommunications)","level":2,"score":0.5996000170707703},{"id":"https://openalex.org/C21200559","wikidata":"https://www.wikidata.org/wiki/Q7451068","display_name":"Sensitivity (control systems)","level":2,"score":0.5838000178337097},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.536300003528595},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5300999879837036},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.4578000009059906},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4293999969959259},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39410001039505005},{"id":"https://openalex.org/C3018146709","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Anticancer drug","level":3,"score":0.3919999897480011},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.353300005197525},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3280999958515167},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.2816999852657318},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.274399995803833},{"id":"https://openalex.org/C158086472","wikidata":"https://www.wikidata.org/wiki/Q21103287","display_name":"GPX4","level":5,"score":0.272599995136261},{"id":"https://openalex.org/C3020391286","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapeutic drugs","level":3,"score":0.2653000056743622},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2619999945163727},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.26109999418258667},{"id":"https://openalex.org/C203522944","wikidata":"https://www.wikidata.org/wiki/Q288322","display_name":"Autophagy","level":3,"score":0.25769999623298645}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1016/j.tranon.2025.102553","doi":"https://doi.org/10.1016/j.tranon.2025.102553","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.tranon.2025.102553","pdf_url":null,"source":{"id":"https://openalex.org/S106638657","display_name":"Translational Oncology","issn_l":"1936-5233","issn":["1936-5233","1944-7124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12517085","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12517085/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12517085/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transl Oncol","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:11324753","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12517085","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:41033073","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41033073","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:7e266dd6badd432984c24cbca84e64ff","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/7e266dd6badd432984c24cbca84e64ff","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Translational Oncology, Vol 62, Iss , Pp 102553- (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.tranon.2025.102553","doi":"https://doi.org/10.1016/j.tranon.2025.102553","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.tranon.2025.102553","pdf_url":null,"source":{"id":"https://openalex.org/S106638657","display_name":"Translational Oncology","issn_l":"1936-5233","issn":["1936-5233","1944-7124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5934959426","display_name":null,"funder_award_id":"202401AY070001-146","funder_id":"https://openalex.org/F4320322268","funder_display_name":"Kunming Medical University"},{"id":"https://openalex.org/G8206644232","display_name":null,"funder_award_id":"202301AC070250","funder_id":"https://openalex.org/F4320322268","funder_display_name":"Kunming Medical University"}],"funders":[{"id":"https://openalex.org/F4320322268","display_name":"Kunming Medical University","ror":"https://ror.org/038c3w259"},{"id":"https://openalex.org/F4320325440","display_name":"Yunnan Provincial Science and Technology Department","ror":"https://ror.org/03whqdf70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4414710210.pdf","grobid_xml":"https://content.openalex.org/works/W4414710210.grobid-xml"},"referenced_works_count":62,"referenced_works":["https://openalex.org/W2163005196","https://openalex.org/W2311489434","https://openalex.org/W2517329137","https://openalex.org/W2768204493","https://openalex.org/W2773145335","https://openalex.org/W2794127903","https://openalex.org/W2796067155","https://openalex.org/W2801988573","https://openalex.org/W2909817598","https://openalex.org/W2917452836","https://openalex.org/W2924471609","https://openalex.org/W2941033601","https://openalex.org/W2946725599","https://openalex.org/W2972497510","https://openalex.org/W2976099163","https://openalex.org/W2990699496","https://openalex.org/W2991274658","https://openalex.org/W3000513632","https://openalex.org/W3001759208","https://openalex.org/W3011095580","https://openalex.org/W3019785310","https://openalex.org/W3034123120","https://openalex.org/W3120588454","https://openalex.org/W3126450731","https://openalex.org/W3128224435","https://openalex.org/W3131505775","https://openalex.org/W3137764588","https://openalex.org/W3138498842","https://openalex.org/W3157232612","https://openalex.org/W3178906518","https://openalex.org/W3192916208","https://openalex.org/W3198144476","https://openalex.org/W3207260749","https://openalex.org/W4220730237","https://openalex.org/W4226367800","https://openalex.org/W4232620598","https://openalex.org/W4293090681","https://openalex.org/W4293207281","https://openalex.org/W4307240874","https://openalex.org/W4312221827","https://openalex.org/W4315709997","https://openalex.org/W4320879153","https://openalex.org/W4323667779","https://openalex.org/W4361204548","https://openalex.org/W4383341285","https://openalex.org/W4385851748","https://openalex.org/W4387580471","https://openalex.org/W4387866149","https://openalex.org/W4387967423","https://openalex.org/W4388727962","https://openalex.org/W4389100740","https://openalex.org/W4390952234","https://openalex.org/W4392241598","https://openalex.org/W4394576715","https://openalex.org/W4400348283","https://openalex.org/W4400594747","https://openalex.org/W4402622745","https://openalex.org/W4403298127","https://openalex.org/W4404901809","https://openalex.org/W4407757427","https://openalex.org/W4408032751","https://openalex.org/W4410259229"],"related_works":["https://openalex.org/W7138322836","https://openalex.org/W4410119523","https://openalex.org/W4390014632","https://openalex.org/W4414460673","https://openalex.org/W7223087377","https://openalex.org/W4383341285","https://openalex.org/W7160233418","https://openalex.org/W4416912981","https://openalex.org/W7162686110","https://openalex.org/W4399239636"],"abstract_inverted_index":{"\u2022":[0,9,19,31],"The":[1,82],"expression":[2,124,273],"of":[3,24,33,84,92,182,192,205,252,291,308],"USP11":[4,10,20,34,71,93,171,183,206,247,265,292],"was":[5,87,103,125,155,172],"upregulated":[6,173],"in":[7,14,35,55,62,78,100,174,195,211,219,227,244,282,293,298],"HCC.":[8,101,309],"inhibited":[11,21,37,186,249],"Erastin-induced":[12],"ferroptosis":[13,42,73,95,243,278,294],"HCC":[15,25,79,107,175,193,245,253,283],"cells":[16,26,194,223,254],"through":[17,29,58],"NRF2.":[18,30],"the":[22,67,90,187,250,288,306],"sensitivity":[23,44,75,97,251,281],"to":[27,45,76,88,98,208,255],"taxanes":[28,77,99,256],"Knockdown":[32],"vivo":[36],"tumor":[38,56],"growth":[39],"and":[40,43,74,96,115,117,122,136,140,151,165,178,190,216,221,236,259,279,295],"promoted":[41,184],"taxanes.":[46],"Ubiquitin-specific":[47],"protease":[48],"11":[49,234],"(USP11)":[50],"plays":[51],"a":[52,209,262,301],"significant":[53],"role":[54,290],"progression":[57],"various":[59],"mechanisms.":[60],"However,":[61],"hepatocellular":[63],"carcinoma":[64],"(HCC)":[65],"research,":[66],"mechanism":[68],"by":[69,157,202],"which":[70],"impacts":[72],"remains":[80],"ambiguous.":[81],"aim":[83],"this":[85],"study":[86],"investigate":[89],"effects":[91],"on":[94,105],"Research":[102],"conducted":[104],"clinical":[106,176],"specimens,":[108],"cell":[109,145],"lines":[110],"(THLE2,":[111],"HepG2,":[112],"SNU449,":[113],"Huh7,":[114],"Hep3B),":[116],"subcutaneous":[118],"tumorigenesis":[119],"models.":[120],"Gene":[121],"protein":[123],"detected":[126,143],"using":[127,144],"real-time":[128],"quantitative":[129],"polymerase":[130],"chain":[131],"reaction":[132],"(RT\u2012qPCR),":[133],"western":[134],"blotting,":[135],"immunohistochemistry.":[137],"Cell":[138],"proliferation":[139],"migration":[141,189],"were":[142],"counting":[146],"kit-8":[147],"(CCK-8),":[148],"colony,":[149],"scratch,":[150],"Transwell":[152],"assays.":[153],"Ferroptosis":[154],"evaluated":[156],"Fe":[158,212],"2+":[159,213],",":[160,197,214],"glutathione":[161,237],"(GSH),":[162],"malondialdehyde":[163],"(MDA)":[164],"reactive":[166],"oxygen":[167],"species":[168],"(ROS)-related":[169],"indices.":[170],"tissues,":[177],"overexpression":[179,204],"or":[180,185],"knockdown":[181],"proliferation,":[188],"invasion":[191],"vitro":[196],"respectively.":[198],"Furthermore,":[199],"when":[200],"triggered":[201],"erastin,":[203],"led":[207],"reduction":[210],"MDA,":[215],"ROS":[217],"levels":[218],"HepG2":[220],"SNU449":[222],"but":[224],"an":[225],"increase":[226],"GSH,":[228],"solute":[229],"carrier":[230],"family":[231],"7":[232],"member":[233],"(SLC7A11),":[235],"peroxidase":[238],"4":[239],"(GPX4),":[240],"thus":[241,276],"inhibiting":[242],"cells.":[246,284],"also":[248],"(paclitaxel,":[257],"docetaxel,":[258],"cabazitaxel).":[260],"From":[261],"mechanistic":[263],"standpoint,":[264],"enhanced":[266],"nuclear":[267],"factor":[268,270],"erythroid-2-related":[269],"2":[271],"(NRF2)":[272],"via":[274],"deubiquitination,":[275],"reducing":[277],"taxane":[280],"This":[285],"research":[286],"highlights":[287],"crucial":[289],"drug":[296],"resistance":[297],"HCC,":[299],"identifying":[300],"new":[302],"potential":[303],"target":[304],"for":[305],"treatment":[307]},"counts_by_year":[{"year":2026,"cited_by_count":3}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2025-10-10T00:00:00"}